Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study

Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients

(2021) François Schiele et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany

(2021) Ingo Ahrens et al.   ADVANCES IN THERAPY

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study

(2020) Ali Allahyari et al.   EUROPEAN HEART JOURNAL

Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction

(2020) Baris Gencer et al.   JAMA Cardiology

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review

(2018) Dasha Cherepanov et al.   CURRENT MEDICAL RESEARCH AND OPINION

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

(2018) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature

(2016) Susanna M. Wallerstedt et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Cardiovascular disease in Europe: epidemiological update 2016

(2016) Nick Townsend et al.   EUROPEAN HEART JOURNAL

Registers of the Swedish total population and their use in medical research

(2016) Jonas F. Ludvigsson et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

An International Model to Predict Recurrent Cardiovascular Disease

(2012) Peter W.F. Wilson et al.   AMERICAN JOURNAL OF MEDICINE

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries

(2011) Gregory A Roth et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET